Compound information
- Natural Products
- ZC1285205
- Molecular Formula
- C15H12FNO3S
- Molecular Weight
- 305.052192464 g/mol
- Structure
-
- IUPAC Name
- N-[4-(4-fluorophenyl)sulfonylphenyl]prop-2-enamide
- InChI
- InChI=1S/C15H12FNO3S/c1-2-15(18)17-12-5-9-14(10-6-12)21(19,20)13-7-3-11(16)4-8-13/h2-10H,1H2,(H,17,18)
- InChI Key
- PVAUCKZBDIDWQR-UHFFFAOYSA-N
- SMILES
- C=CC(=O)Nc1ccc(S(=O)(=O)c2ccc(F)cc2)cc1
- Source
- ZINC000159834754
Warheads
- Acrylamide
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 21 | Ring Count | 2 |
Heteroatom Count | 6 | Rotatable Bond Count | 4 |
Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 63.24 Å2 | LogP | 2.872 |
LogS | -4.323 | LogD | 2.885 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.214 | Pgp substrate | 0.888 |
HIA | 0.969 | F20 % | 0.994 |
F30 % | 0.971 | Caco-2 | -4.553 |
MDCK | -4.73 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.069 | PPB | 94.878 |
VD | 0.718 | Fu | 2.159 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.034 | CYP1A2 substrate | 0.704 |
CYP2A6 substrate | 0.452 | CYP2B6 substrate | 0.47 |
CYP2C19 inhibitor | 0.565 | CYP2C19 substrate | 0.948 |
CYP2C8 substrate | 0.949 | CYP2C9 inhibitor | 0.132 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.045 |
CYP2D6 substrate | 0.963 | CYP2E1 substrate | 0.959 |
CYP3A4 inhibitor | 0.028 | CYP3A4 substrate | 0.993 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.036 | CL | 0.624 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.005 | Hepatotoxicity | 0.993 |
Mutagenicity | 0.008 | Rat Oral Acute Toxicity | 0.092 |
FDAMDD | 0.112 | Skin Sensitization | 0.173 |
Carcinogenicity | 0.659 | Eye Corrosion | 0.01 |
Eye Irritation | 0.628 | Respiratory Toxicity | 0.002 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.824 | IGC50 | 3.934 |
LC50FM | 3.849 | LC50DM | 4.523 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.166 | NR-AR-LBD | 0.288 |
NR-AhR | 0.112 | NR-Aromatase | 0.352 |
NR-ER | 0.264 | NR-ER-LBD | 0.335 |
NR-PPAR-gamma | 0.688 | SR-ARE | 0.544 |
SR-ATAD5 | 0.253 | SR-HSE | 0.031 |
SR-MMP | 0.855 | SR-p53 | 0.059 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.